Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, octobre 17
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Pfizer Inc
PFE
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$29.57
0.13
0.44%
Dern. MÀJ: Oct 16, 7:58 PM
$29.60
0.16
0.54%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Dividendes
Comparer
Rapport sur les stocks
Privacy Manager
Pfizer Financials
Pfizer (PFE) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone
Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on potential deal to reopen Strait of Hormuz.
Avi Kapoor
Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss
Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.
Vandana Singh
Stock Market Today: S&P 500, Dow and Nasdaq Futures Gain as Scott Bessent Says Hormuz Deal Could Come Soon— Caterpiller, Palantir in Focus (UPDATED)
U.S. stock futures edged higher on Tuesday, with Dow, S&P 500 and Nasdaq 100 futures advancing after Wall Street's broad rally on Monday.
Eva Mathew
PRO
Pfizer Q2 Adj. EPS $0.77 Beats $0.69 Estimate, Sales $15.034B Beat $14.412B Estimate
Pfizer (NYSE:PFE) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.69 by 11.59 percent. This is a 1.28 percent decrease over earnings of $0.78 per share from the same period
Benzinga Newsdesk
PRO
Pfizer Affirms FY2026 Adj EPS Guidance of $2.80-$3.00 vs $2.95 Est; Raises FY2026 Sales Guidance from $59.500B-$62.500B to $60.500B-$62.500B vs $61.793B Est
Pfizer (NYSE:PFE) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.95 analyst estimate. Raises FY2026 sales outlook from $59.500 billion-$62.500 billion to $60.500 billion-$62.500 billion vs $61.793
Benzinga Newsdesk
Dow Closes at Record High, Nasdaq Surges 2%, but Fear & Greed Index Signals Investors Are Still Playing It Safe
Fear & Greed Index improves, Dow Jones hits record high, oil prices fall after Trump's Iran decision. CNH & Makemytrip stocks gain on earnings.
Avi Kapoor
